ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

ClinicalTrials.gov ID: NCT03721978

Public ClinicalTrials.gov record NCT03721978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix

Study identification

NCT ID
NCT03721978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Inovio Pharmaceuticals
Industry
Enrollment
203 participants

Conditions and interventions

Interventions

  • CELLECTRA™-5PSP Device
  • Matched Placebo Biological
  • VGX-3100 Biological

Device · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 27, 2019
Primary completion
Aug 22, 2022
Completion
Sep 14, 2022
Last update posted
Oct 16, 2024

2019 – 2022

United States locations

U.S. sites
27
U.S. states
20
U.S. cities
27
Facility City State ZIP Site status
Visions Clinical Research- Tucson Tucson Arizona 85712
Nuvance Health Danbury Connecticut 06810
Christiana Care Health System Newark Delaware 19713
Altus Research Lake Worth Florida 33461
Salom and Tangir LLC Miramar Florida 33027
Precision Clinical Research, LLC Sunrise Florida 33351
Augusta University Augusta Georgia 30912
Affinity Clinical Research Institute Oak Brook Illinois 60523
Praetorian Pharmaceutical Research, LLC Marrero Louisiana 70072
Unified Women's Clinical Research - Hagerstown Hagerstown Maryland 21740
Boston Medical Center Boston Massachusetts 02118
Saginaw Valley Medical Research Group LLC Saginaw Michigan 48604
Meridian Clinical Research Norfolk Norfolk Nebraska 68701
New Jersey Medical School Newark New Jersey 07103
Columbia University Medical Center New York New York 10032
Suffolk Obstetrics and Gynecology Port Jefferson New York 11777
Montefiore Medical Center The Bronx New York 10583
Unified Women's Clinical Research - Greensboro Greensboro North Carolina 27408
Unified Women's Clinical Research - Morehead City Morehead City North Carolina 28557
Lyndhurst Clinical Research Winston-Salem North Carolina 27103
ClinOhio Research Services Columbus Ohio 43213
Obstetrics & Gynecology Associates, Inc. Fairfield Ohio 45014
Frontier Clinical Research-Smithfield Smithfield Pennsylvania 15478
Venus Gynecology, LLC Myrtle Beach South Carolina 29572
Women's Physician Group Suite 203 Memphis Tennessee 38119
Storks Research Sugar Land Texas 77479
Group For Women - Tidewater Clinical Research Inc. Virginia Beach Virginia 23456

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03721978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03721978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →